html
<!DOCTYPE html>
<html>
<head>
    <title>æˆ‘çš„è®°äº‹æœ¬</title>
    <style>
        body { max-width: 800px; margin: 20px auto; padding: 20px; font-family: Arial; }
        #content { border: 1px solid #ccc; padding: 20px; min-height: 300px; }
    </style>
</head>
<body>
    <h1>ğŸ“ æˆ‘çš„è®°äº‹ç©ºé—´</h1>
    <div id="content">
        <!-- åœ¨è¿™é‡Œç¼–è¾‘ä½ çš„æ–‡å­— -->
        <p>
åœ°é«˜è¾›(DIG)åŸä½æ‚äº¤ï¼ˆCISHï¼‰è¯•å‰‚ç›’

äº§å“ä¼˜åŠ¿ï¼š

1. ä¿¡å·æ¸…æ™°ï¼Œå®šä½å‡†ç¡®ï¼Œç»“æœåˆ¤å®šç›´è§‚å¯é ã€‚

2. æ ¹æ®å®¢æˆ·éœ€æ±‚å®šåˆ¶ä¸ªæ€§åŒ–æ¢é’ˆã€‚

3. ç‰¹å¼‚æ€§å¼ºï¼Œçµæ•åº¦é«˜ï¼ŒèƒŒæ™¯ä½ã€‚

4. æ¢é’ˆæ€§èƒ½ç¨³å®šï¼Œä½æ¸©ä¿å­˜ä¸€å¹´ä»¥ä¸Šã€‚

5. æ“ä½œç®€å•ï¼Œå®‰å…¨ã€å¿«é€Ÿï¼Œé‡å¤æ€§å¥½ã€‚
è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes1006 CISHï¼ˆçŸ­é“¾ï¼‰

è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes1007 CISHï¼ˆé•¿é“¾ï¼‰

è§å…‰åŸä½æ‚äº¤(FISH)è¯•å‰‚ç›’

è¯¦ç»†ä»‹ç»

ä¼¯ä¿¡ç”Ÿç‰©å»ºç«‹äº†è§å…‰åŸä½æ‚äº¤æ¢é’ˆï¼ˆFISH Probeï¼‰åˆ¶å¤‡å¹³å°ï¼Œæ‰¿æ¥è§å…‰åŸä½æ‚äº¤è¯•å‰‚ç›’å®šåˆ¶ä¸šåŠ¡ï¼Œå¯æ ¹æ®å®¢æˆ·éœ€æ±‚è¿›è¡Œä¸ªæ€§åŒ–å®šåˆ¶ã€‚

è¯¥è¯•å‰‚ç›’ä¸»è¦ç”¨äºæ£€æµ‹æ ·æœ¬ä¸­ç›®çš„åŸºå› çš„è¡¨è¾¾é‡ä¸è¡¨è¾¾éƒ¨ä½ï¼Œå¯åº”ç”¨äºç»„ç»‡åˆ‡ç‰‡ï¼ˆçŸ³èœ¡åˆ‡ç‰‡/å†°å†»åˆ‡ç‰‡ï¼‰ã€ç»†èƒçˆ¬ç‰‡ä¸æŸ“è‰²ä½“ç‰‡ç­‰çš„æ£€æµ‹ã€‚

ä¼¯ä¿¡ç”Ÿç‰©é‡‡ç”¨ä»ç ”ç©¶ç‰©ç§è‡ªä½“è·å–ç‰¹å¼‚æ€§æ¢é’ˆå¹¶è¿›è¡ŒåŒ–å­¦å…±ä»·æ–¹å¼ä¸è§å…‰ç´ è¿æ¥ã€‚

è‡ªä½“è§å…‰æ¢é’ˆå…·æœ‰æ˜æ˜¾çš„ä¼˜è¶Šæ€§ï¼šçµæ•åº¦é«˜ï¼Œå…‰ç¨³å®šæ€§å¥½ï¼Œè§å…‰å¯¿å‘½é•¿ï¼›æœ€å¤§çš„ä¼˜åŠ¿å°±æ˜¯è‡ªä½“æ¢é’ˆå¯ä»¥æœ‰æ•ˆçš„é™ä½è‡ªä½“çš„éç‰¹å¼‚è§å…‰å¹²æ‰°ï¼Œè¾¾åˆ°æ›´åŠ é«˜æ•ˆç‰¹å¼‚çš„åŸºå› æ£€æµ‹ä¿¡å·ã€‚å¯æ›¿ä»£ä¼ ç»Ÿçš„æ¢é’ˆæ£€æµ‹ï¼Œæ»¡è¶³å›½å†…å¤–ç§‘ç ”å·¥ä½œè€…å¯¹é«˜è´¨é‡çš„è§å…‰æ¢é’ˆåŸä½æ‚äº¤è¯•å‰‚ç›’çš„å®éªŒéœ€æ±‚ã€‚

ä¼¯ä¿¡ç”Ÿç‰©è§å…‰åŸä½æ‚äº¤è¯•å‰‚ç›’ï¼Œè‡ªä¸Šå¸‚ä»¥æ¥æ·±å—å¹¿å¤§ç§‘ç ”ç”¨æˆ·çš„æ¬¢è¿å’Œè‚¯å®šï¼Œä¸ºä¸­å›½ç§‘å­¦é™¢ã€ä¸­å±±å¤§å­¦åŒ»å­¦é™¢åŠé™„å±åŒ»é™¢ã€å—æ–¹åŒ»ç§‘å¤§å­¦åŒ»å­¦é™¢åŠé™„å±åŒ»é™¢ã€é¦™æ¸¯å¤§å­¦ã€åŒ—äº¬å¤§å­¦åŒ»å­¦éƒ¨åŠé™„å±åŒ»é™¢ã€ä¸œå—å¤§å­¦åŒ»å­¦é™¢ã€æ±Ÿè¥¿å†œä¸šå¤§å­¦ã€åä¸­ç§‘æŠ€å¤§å­¦åŒæµåŒ»å­¦é™¢ç­‰å›½å†…ä¸€æµç§‘ç ”é™¢æ‰€ã€åŒ»ç–—æœºæ„åŠè·¨å›½ç”Ÿç‰©ä¼ä¸šç­‰è¿‘åƒå®¶ç”¨æˆ·æä¾›äº†ä¼˜è´¨çš„æœåŠ¡ã€‚

åŒæ—¶ç»è¿‡å¤šå¹´çš„ç§¯ç´¯ï¼Œ2011å¹´å»ºç«‹äº†åˆ†å­æ¢é’ˆç ”å‘ä¸­å¿ƒï¼Œä¼¯ä¿¡ç”Ÿç‰©æ‹¥æœ‰å¼ºå¤§çš„è§å…‰åŸä½æ‚äº¤æŠ€æœ¯å›¢é˜Ÿï¼Œä¸ºå®¢æˆ·åœ¨è¯•å‰‚ç›’ä½¿ç”¨ä¸­é‡åˆ°çš„å„ç§é—®é¢˜ç»™äºˆæŠ€æœ¯æ”¯æŒå’Œè§£ç­”ã€‚

äº§å“ä¼˜åŠ¿ï¼š

1. æ¢é’ˆåˆ¶å¤‡é‡‡ç”¨ç›´æ¥æ ‡è®°æ³•ï¼Œçœå»äº†ä¿¡å·æ”¾å¤§ç³»ç»Ÿã€‚

2. è§å…‰ä¿¡å·å¼ºï¼Œç»“æœåˆ¤å®šç›´è§‚å¯é ã€‚

3. æ ¹æ®å®¢æˆ·éœ€æ±‚å®šåˆ¶ä¸ªæ€§åŒ–æ¢é’ˆã€‚

4. ç‰¹å¼‚æ€§å¼ºï¼Œçµæ•åº¦é«˜ï¼ŒèƒŒæ™¯ä½ã€‚

5. æ¢é’ˆæ€§èƒ½ç¨³å®šï¼Œä½æ¸©ä¿å­˜ä¸€å¹´ä»¥ä¸Šã€‚

6. åŒæ—¶ç¤ºè¸ªæ ¸é…¸å’Œè›‹ç™½çš„å®šä½æƒ…å†µã€‚

7. æ“ä½œç®€å•ï¼Œå®‰å…¨ã€å¿«é€Ÿï¼Œé‡å¤æ€§å¥½ã€‚

è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes1001 RNA-FISHï¼ˆçŸ­é“¾ï¼‰

è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes1002 RNA-FISHï¼ˆé•¿é“¾ï¼‰ 

è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes1011 DNA-FISH

IF-FISHè¯•å‰‚ç›’

å®éªŒåŸç†ï¼š

è§å…‰åŸä½æ‚äº¤ï¼ˆFluorescent in situ hybridization, FISHï¼‰æ˜¯æ ¹æ®å¾…æµ‹æ ¸é…¸åºåˆ—è®¾è®¡ç‰¹å¼‚æ€§çš„è§å…‰ç´ æ ‡è®°å¯¡èšæ ¸è‹·é…¸æ¢é’ˆï¼Œå†ç»è¿‡å…±å˜æ€§-é€€ç«-å¤æ€§ï¼Œä½¿æ¢é’ˆä¸é¶DNA/RNAæŒ‰ç…§ç¢±åŸºäº’è¡¥é…å¯¹åŸåˆ™å½¢æˆæ‚äº¤ä½“ï¼Œæœ€ååˆ©ç”¨è§å…‰æ˜¾å¾®é•œç›´æ¥æ£€æµ‹è§å…‰ä¿¡å·ï¼Œä»è€Œå¯¹ç»„ç»‡ã€ç»†èƒä¸­çš„å¾…æµ‹æ ¸é…¸è¿›è¡Œå®šæ€§ã€åŠå®šé‡æˆ–ç›¸å¯¹å®šä½åˆ†æçš„ä¸€ç§åŸä½æ‚äº¤æŠ€æœ¯

å…ç–«è§å…‰ï¼ˆImmunofluorescence, IFï¼‰åˆç§°è§å…‰æŠ—ä½“æŠ€æœ¯ã€‚å®ƒæ˜¯åœ¨å…ç–«å­¦ã€ç”Ÿç‰©åŒ–å­¦å’Œæ˜¾å¾®é•œæŠ€æœ¯çš„åŸºç¡€ä¸Šå»ºç«‹èµ·æ¥çš„ï¼Œä¸€é¡¹åˆ©ç”¨æŠ—åŸæŠ—ä½“ååº”è¿›è¡Œç»„ç»‡æˆ–ç»†èƒå†…æŠ—åŸç‰©è´¨çš„å®šä½ç¤ºè¸ªæŠ€æœ¯ã€‚

IF-FISHåˆ™æ•´åˆäº†IFå’ŒFISHæŠ€æœ¯ï¼Œå¯ä»¥åŒæ—¶ç¤ºè¸ªæ ¸é…¸åˆ†å­ä¸è›‹ç™½æŠ—åŸåˆ†å­åœ¨ç»†èƒå†…çš„ç›¸å¯¹å®šä½ã€‚

äº§å“ä¼˜åŠ¿ï¼š

1. æ¢é’ˆåˆ¶å¤‡é‡‡ç”¨ç›´æ¥æ ‡è®°æ³•ï¼Œçœå»äº†ä¿¡å·æ”¾å¤§ç³»ç»Ÿã€‚

2. è§å…‰ä¿¡å·å¼ºï¼Œç»“æœåˆ¤å®šç›´è§‚å¯é ã€‚

3. æ ¹æ®å®¢æˆ·éœ€æ±‚å®šåˆ¶ä¸ªæ€§åŒ–æ¢é’ˆã€‚

4. ç‰¹å¼‚æ€§å¼ºï¼Œçµæ•åº¦é«˜ï¼ŒèƒŒæ™¯ä½ã€‚

5. æ¢é’ˆæ€§èƒ½ç¨³å®šï¼Œä½æ¸©ä¿å­˜ä¸€å¹´ä»¥ä¸Šã€‚

6. åŒæ—¶ç¤ºè¸ªæ ¸é…¸å’Œè›‹ç™½çš„å®šä½æƒ…å†µã€‚

7. æ“ä½œç®€å•ï¼Œå®‰å…¨ã€å¿«é€Ÿï¼Œé‡å¤æ€§å¥½ã€‚

è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes1023 IF-FISHï¼ˆçŸ­é“¾ï¼‰

è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes1024 IF-FISHï¼ˆé•¿é“¾ï¼‰

è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes1025 IF-FISHï¼ˆDNAä¸è›‹ç™½å…±å®šä½ï¼‰

CLIP Kit

å®éªŒåŸç†ï¼š




CLIPï¼ˆäº¤è”å…ç–«æ²‰æ·€ï¼‰å®éªŒæ˜¯ä¸€ç§ç”¨äºç ”ç©¶RNAä¸è›‹ç™½è´¨ç›¸äº’ä½œç”¨çš„æŠ€æœ¯ï¼Œé€šè¿‡äº¤è”RNAå’ŒRNAç»“åˆè›‹ç™½ï¼ˆRBPï¼‰ä¹‹é—´çš„ç‰©ç†æ¥è§¦ï¼Œå¹¶åˆ©ç”¨å…ç–«æ²‰æ·€æ¥å¯Œé›†å’Œåˆ†æè¿™äº›RNA-è›‹ç™½è´¨å¤åˆç‰©ï¼›PAR-CLIP æ˜¯ CLIPï¼ˆäº¤è”å…ç–«æ²‰æ·€ï¼‰å®éªŒçš„ä¸€ç§æ”¹è¿›æ–¹æ³•ï¼Œç»“åˆäº†å…‰æ¿€æ´»çš„æ ¸ç³–æ ¸è‹·ï¼ˆé€šå¸¸æ˜¯ 4-thiouridine (4SU) ç­‰ï¼‰æŠ€æœ¯ï¼Œèƒ½å¤Ÿæ›´åŠ é«˜æ•ˆã€ç²¾ç¡®åœ°æ•è· RNA ä¸è›‹ç™½è´¨ä¹‹é—´çš„ç›¸äº’ä½œç”¨ã€‚



CLIP-qPCRï¼ˆcrosslinking-immunoprecipitation and qPCRï¼‰æ˜¯é€šè¿‡å…ç–«å…±æ²‰æ·€RBP-RNAå¤åˆç‰©ï¼Œè·å–çº¯åŒ–åŠæ¶ˆåŒ–ï¼ˆè›‹ç™½é…¶Kã€DNaseIã€RNase T1ï¼‰åçš„RNAï¼Œå¹¶é€šè¿‡å¯¹RNA 3â€™-ç«¯åŠ æ¥å¤´å’Œè®¾è®¡ä¸åŒä½ç‚¹çš„å¼•ç‰©ï¼Œè¿›è¡ŒRNAç»“åˆè›‹ç™½ä½ç‚¹çš„å¯Œé›†æ•ˆç‡æ£€æµ‹ã€‚



CLIP-seqï¼ˆcrosslinking-immunoprecipitation and High throughput sequencingï¼‰æ˜¯é€šè¿‡å…ç–«å…±æ²‰æ·€RBP-RNAå¤åˆç‰©ï¼Œè·å–çº¯åŒ–åŠæ¶ˆåŒ–ï¼ˆè›‹ç™½é…¶Kã€DNaseIã€RNase T1ï¼‰åçš„RNAï¼Œè¿›è¡ŒcDNAæ–‡åº“æ„å»ºä¸æµ‹åºåˆ†æã€‚



äº§å“ä¼˜åŠ¿ï¼š

1.ä¼¯ä¿¡ç‹¬ç«‹ç ”å‘ã€‚

2.ç´«å¤–ç…§å°„æœ‰æ•ˆä¿ƒè¿›ç»†èƒå†…RNAä¸ç›¸åº”çš„RNAç»“åˆè›‹ç™½äº¤è”ï¼Œå¢å¼ºRNAä¸è›‹ç™½çš„ç»“åˆèƒ½åŠ›ã€‚

3.å¯æ£€æµ‹å¤šç§RNAï¼Œå¦‚LncRNAã€mRNAã€microRNAã€‚

4.CLIP-qPCRå¯ç²¾ç¡®å®šä½RNAä¸è›‹ç™½çš„ç»“åˆä½ç‚¹ã€‚

è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes3014-1 CLIP-qPCR

è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes3014-2 CLIP-seq

æ–‡ç« æ¡ˆä¾‹

Articleï¼š o8G-modified circPLCE1 inhibits lung cancer progression via chaperone-mediated autophagy. 
Periodicalsï¼šMolecular Cancer
IFï¼š27.700
Articleï¼šThe CTBP2-PCIF1 complex regulates m6Am modification of mRNA in head and neck squamous cell carcinoma
Periodicalsï¼šThe Journal of Clinical Investigation
IFï¼š15.900
Articleï¼šCircFOXP1 alleviates brain injury after acute ischemic stroke by regulating STAT3/apoptotic signaling
Periodicalsï¼šTranslational Research
IFï¼š10.171

å…ç–«å…±æ²‰æ·€ï¼ˆCo-Immunoprecipitation, Co-IPï¼‰è¯•å‰‚ç›’ï¼š
å®éªŒåŸç†ï¼š
ç»†èƒåœ¨éå˜æ€§æ¡ä»¶ä¸‹è¢«è£‚è§£æ—¶ï¼Œç»†èƒå†…è®¸å¤šâ€œè›‹ç™½è´¨-è›‹ç™½è´¨â€ç›¸äº’ä½œç”¨å¤åˆä½“è¢«å®Œæ•´ä¿ç•™ä¸‹æ¥ã€‚åˆ©ç”¨ç›®æ ‡è›‹ç™½è´¨çš„ç‰¹å¼‚æ€§æŠ—ä½“è¿›è¡Œå…ç–«æ²‰æ·€ï¼Œå†é€šè¿‡å˜æ€§å‡èƒ¶ç”µæ³³åˆ†ç¦»æ‰€å¾—è›‹ç™½è´¨å¤åˆä½“ï¼Œä»¥æ­¤å®šæ€§æˆ–å®šé‡åˆ†æå‡ ç§è›‹ç™½è´¨ä¹‹é—´çš„ç›¸äº’ä½œç”¨åŠ›ã€‚
äº§å“ä¼˜åŠ¿ï¼š
1. ä¼¯ä¿¡ç‹¬ç«‹ç ”å‘ï¼Œå…·æœ‰è‡ªä¸»çŸ¥è¯†äº§æƒã€‚
2. é…å¤‡å®Œæ•´ï¼šè¯¥è¯•å‰‚ç›’åŒ…å«äº¤è”å‰‚ï¼Œå¯ä½¿æŠ—ä½“ä¸ç¼è„‚ç³–ç äº¤è”ï¼Œæ´—è„±æ—¶åªæ”¶é›†è¯±é¥µè›‹ç™½å’Œæ•è·è›‹ç™½ã€‚
3. åŒä¸€ä¸ªæŠ—ä½“æ—¢å¯ç”¨äºå…ç–«æ²‰æ·€ï¼Œåˆå¯ç”¨äºWBæ£€æµ‹ã€‚
4. æ“ä½œç®€å•ã€è€—æ—¶çŸ­ã€ç»“æœå®¢è§‚å‡†ç¡®ã€‚
è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes3011 Co-IP 
æ–‡ç« æ¡ˆä¾‹





Articleï¼šLactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer.

Periodicalsï¼šMolecular Cancer

IFï¼š27.700




Articleï¼š o8G-modified circPLCE1 inhibits lung cancer progression via chaperone-mediated autophagy. 

Periodicalsï¼šMolecular Cancer

IFï¼š27.700



Articleï¼šCircAKT3 promotes prostate cancer proliferation and metastasis by enhancing the binding of RPS27A and RPL11.

Periodicalsï¼šMolecular Cancer

IFï¼š27.700




å‡èƒ¶è¿ç§»æˆ–ç”µæ³³è¿ç§»ç‡æ£€æµ‹è¯•å‰‚ç›’ï¼ˆEMSAè¯•å‰‚ç›’ï¼‰ï¼š
å®éªŒåŸç†ï¼š
å‡èƒ¶è¿ç§»æˆ–ç”µæ³³è¿ç§»ç‡æ£€æµ‹(Electrophoretic mobility shift assayï¼ŒEMSA)æ˜¯ç ”ç©¶å¯åŠ¨å­ç»“åˆè›‹ç™½çš„ç»å…¸æ–¹æ³•ï¼Œä¸»è¦åº”ç”¨äºå®šæ€§å’Œå®šé‡åˆ†ææ ¸é…¸è›‹ç™½ç›¸äº’ä½œç”¨ã€‚
é’ˆå¯¹ç›®æ ‡åŒºåŸŸè®¾è®¡ç‰¹å¼‚æ€§æ ¸é…¸æ¢é’ˆï¼Œå¹¶è¿›è¡Œæœ«ç«¯ç”Ÿç‰©ç´ æ ‡è®°ï¼›è¯¥æ¢é’ˆä¸è›‹ç™½è´¨ç»“åˆå½¢æˆå¤åˆç‰©ï¼Œç”µæ³³æ—¶åœ¨å‡èƒ¶ä¸­ç§»åŠ¨çš„é€Ÿåº¦æ…¢ï¼ˆç›¸å¯¹äºæ²¡æœ‰ç»“åˆè›‹ç™½çš„æ¢é’ˆï¼‰ï¼Œå³è¡¨ç°ä¸ºæ¡å¸¦ç›¸å¯¹æ»åã€‚
è¯¥æ–¹æ³•ä¸ä»…ç®€å•è¿…é€Ÿã€çµæ•åº¦é«˜ï¼Œè¿˜å¯ä»¥ç”¨ç«äº‰æ€§è¯•éªŒæ¥è¯„ä»·è›‹ç™½å’Œæ ¸é…¸ç»“åˆçš„ç‰¹æ€§ã€‚ç›®å‰ç”¨äºæ£€æµ‹DNA/RNAç»“åˆè›‹ç™½ï¼Œå¹¶å¯é€šè¿‡åŠ å…¥ç‰¹å¼‚æ€§æŠ—ä½“æ¥æ£€æµ‹ç‰¹å®šçš„è›‹ç™½è´¨ï¼Œæˆ–æ˜¯ç»“åˆè›‹ç™½åŒå‘ç”µæ³³ä¸è´¨è°±æŠ€æœ¯é‰´å®šåˆ†ææœªçŸ¥è›‹ç™½ã€‚
é€šè¿‡DNA-EMSAå¯ä»¥ç ”ç©¶ç»†èƒå†…ä¸€äº›è½¬å½•å› å­å¯¹ç‰¹å®šåŸºå› çš„æ¿€æ´»æ°´å¹³ã€‚æœ¬è¯•å‰‚ç›’æä¾›äº†è¿›è¡ŒDNA-EMSAå®éªŒçš„ä¸»è¦è¯•å‰‚ï¼ŒåŒ…æ‹¬è›‹ç™½æå–ã€è›‹ç™½-DNAç»“åˆã€ç”µæ³³ä¸åŒ–å­¦å‘å…‰ç­‰ï¼Œä½¿æ•´ä½“å®éªŒå˜å¾—ç®€å•æ–¹ä¾¿ã€‚DNA-EMSA/Gel-Shiftç»“åˆä½“ç³»ä¸­å«æœ‰poly(dI-dC)ç­‰æœ‰æ•ˆæˆåˆ†ï¼Œå…¶ä¸­ï¼Œpoly(dI-dC)çš„æµ“åº¦ç»è¿‡ä¼˜åŒ–ï¼Œå¯ä»¥å¾ˆå¥½åœ°æ¶ˆé™¤è›‹ç™½å’Œæ ‡è®°æ¢é’ˆé—´çš„éç‰¹å¼‚æ€§ç»“åˆï¼ŒåŒæ—¶åˆä¸ä¼šå‡å¼±ç›®çš„è½¬å½•å› å­å’Œæ ‡è®°æ¢é’ˆé—´çš„ç»“åˆã€‚æ­¤å¤–ï¼Œæœ¬è¯•å‰‚ç›’ç»å»é™¤RNAé…¶å¤„ç†ï¼Œä¸€å®šç¨‹åº¦ä¸Šé¿å…äº†å®éªŒè¿‡ç¨‹ä¸­RNAé™è§£ã€‚
äº§å“ä¼˜åŠ¿ï¼š
1. å®‰å…¨ç¯ä¿ï¼šé‡‡ç”¨éåŒä½ç´ çš„åŒ–å­¦å‘å…‰æ£€æµ‹ç³»ç»Ÿï¼Œå…é™¤æ”¾å°„æ€§çš„å±é™©ä¸å¤„ç†åŒä½ç´ åºŸç‰©çš„éº»çƒ¦ï¼Œå‡å°‘ç¯å¢ƒæ±¡æŸ“ï¼›æ— éœ€ä¸“é—¨çš„åŒä½ç´ æ“ä½œå®¤ï¼Œæ˜“äºä½¿ç”¨æ¨å¹¿ã€‚
2. é«˜çµæ•åº¦ï¼šæ£€æµ‹çµæ•åº¦é«˜ï¼ŒèƒŒæ™¯å¹²æ‰°æ›´ä½ã€‚
3. å¿«é€Ÿçœæ—¶ï¼šä»æ ‡è®°æ¢é’ˆåˆ°ç»“æœåˆ†æï¼Œå…¨éƒ¨å®éªŒåªéœ€5å°æ—¶ã€‚
4. ç¨³å®šå¯é ï¼šDNAæœ«ç«¯æ ‡è®°ç”Ÿç‰©ç´ ï¼Œä¸å½±å“è›‹ç™½ç»“åˆä½ç‚¹ï¼›æ ‡è®°å¥½çš„DNA/RNAå¯ä»¥ä¿å­˜ä¸€å¹´ã€‚
5. é…å¤‡å®Œæ•´ï¼šé…å¤‡ä¼¯ä¿¡ç”Ÿç‰©ç»†èƒæ ¸æå–è¯•å‰‚ç›’ã€‚
6. ä¸ªæ€§åŒ–æœåŠ¡ï¼šå¯æ ¹æ®ç ”ç©¶éœ€è¦å®šåˆ¶ä¸ªæ€§åŒ–é«˜çµæ•åº¦æ¢é’ˆã€‚
è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes5003 DNA-EMSA  
è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes5107 RNA-EMSA 
æ–‡ç« æ¡ˆä¾‹
Articleï¼šThe RNA-binding protein hnRNP F is required for the germinal center B cell response

Periodicalsï¼šNature Communications

IFï¼š16.600

Articleï¼šAn inducible long noncoding RNA, LncZFHX2, facilitates DNA repair to mediate osteoarthritis pathology


Periodicalsï¼šRedox Biology

IFï¼š11.400

Articleï¼šDGW1, encoding an hnRNP-like RNA binding protein, positively regulates grain size and weight by interacting with GW6 mRNA. 


Periodicalsï¼šPlant biotechnology journal

IFï¼š10.100

GST pulldownè¯•å‰‚ç›’
å®éªŒåŸç†ï¼š

å°†â€œé¶è›‹ç™½-GSTâ€èåˆè›‹ç™½äº²å’Œå›ºåŒ–åœ¨ç£ç ä¸Šï¼Œå……å½“ä¸€ç§èƒ½å¤Ÿä¸ç›®çš„è›‹ç™½äº²å’Œå¸é™„çš„â€œè¯±é¥µè›‹ç™½â€ï¼Œå½“å¾…æµ‹è›‹ç™½æº¶æ¶²ä¸ç£ç å…±å­µè‚²æ—¶ï¼Œå¯ä»ä¸­æ•è·ä¸å…¶äº’ä½œçš„â€œæ•è·è›‹ç™½â€ï¼ˆå³ç›®çš„è›‹ç™½ï¼‰ï¼Œæ‰€å½¢æˆçš„â€œè¯±é¥µ-æ•è·â€ç»“åˆç‰©æœ€ç»ˆè¢«æ´—è„±ä¸‹æ¥ï¼Œå†ç»è¿‡SDS-PAGEåˆ†ç¦»å’ŒWestern Blotæ£€æµ‹ï¼Œä»è€Œè¯å®ä¸¤ç§è›‹ç™½è´¨é—´çš„ç›¸äº’ä½œç”¨ã€‚

 â€œè¯±é¥µè›‹ç™½â€å’Œâ€œæ•è·è›‹ç™½â€å‡å¯é€šè¿‡ç»†èƒè£‚è§£ç‰©ã€çº¯åŒ–çš„è›‹ç™½è´¨ã€è¡¨è¾¾ç³»ç»Ÿä»¥åŠä½“å¤–è½¬å½•ç¿»è¯‘ç³»ç»Ÿç­‰æ–¹æ³•è·å¾—ã€‚

äº§å“ä¼˜åŠ¿ï¼š

1. ä¼¯ä¿¡ç‹¬ç«‹ç ”å‘ã€‚

2. é…å¤‡å®Œæ•´ï¼šæä¾›åŒ…æ‹¬â€œè¯±é¥µè›‹ç™½â€å’Œâ€œæ•è·è›‹ç™½â€åˆ¶å¤‡è¿‡ç¨‹åœ¨å†…çš„æ‰€éœ€è¯•å‰‚ä¸è¯¦ç»†æ“ä½œè¯´æ˜ä¹¦ã€‚

3. å®éªŒå®¤æ™®é€šè®¾å¤‡å³å¯æ“ä½œã€‚

4.æ“ä½œè¿‡ç¨‹ç®€å•ã€è€—æ—¶çŸ­ï¼Œç»“æœå®¢è§‚å‡†ç¡®ã€‚
è¯¦è§äº§å“è¯´æ˜ä¹¦ï¼šBes3012 GST-pulldown
æ–‡ç« æ¡ˆä¾‹

Articleï¼šLactylation of Histone H3k18 and Egr1 Promotes Endothelial Glycocalyx Degradation in Sepsis-Induced Acute Lung Injury. 

Periodicalsï¼šAdvanced science (Weinheim, Baden-Wurttemberg, Germany)

IFï¼š14.300

Articleï¼š Leptin-mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer.

Periodicalsï¼šCancer Communications

IFï¼š20.100

Articleï¼šHRG switches TNFR1-mediated cell survival to apoptosis in Hepatocellular Carcinoma
Periodicalsï¼šTheranostics

IFï¼š12.400
M5C MeRIPè¯•å‰‚ç›’
å®éªŒä»‹ç»
RNAç”²åŸºåŒ–æŒ‡å‘ç”Ÿåœ¨RNAåˆ†å­ä¸Šä¸åŒä½ç½®çš„ç”²åŸºåŒ–ä¿®é¥°ç°è±¡ï¼Œå±äºè½¬å½•åä¿®é¥°ï¼Œå¸¸è§çš„ç”²åŸºåŒ–ä¿®é¥°æ–¹å¼æœ‰6-ç”²åŸºè…ºå˜Œå‘¤(N6-methyladenosineï¼Œm6A)å’Œ5-ç”²åŸºèƒå˜§å•¶(C5-methylcytidineï¼Œm5C)ä»¥åŠ7-ç”²åŸºé¸Ÿå˜Œå‘¤(N7-methylguanosineï¼Œm7G)ç­‰ã€‚RNAç”²åŸºåŒ–åœ¨è°ƒæ§åŸºå› è¡¨è¾¾ã€å‰ªæ¥ã€RNAç¼–è¾‘ã€RNAç¨³å®šæ€§ã€æ§åˆ¶mRNAå¯¿å‘½å’Œé™è§£ã€ä»‹å¯¼ç¯çŠ¶RNAç¿»è¯‘ç­‰æ–¹é¢å¯èƒ½æ‰®æ¼”é‡è¦è§’è‰²ã€‚åˆ©ç”¨ç”²åŸºåŒ–RNAå…ç–«å…±æ²‰æ·€(Methylated RNA Immunoprecipitationï¼ŒMeRIP)æŠ€æœ¯ï¼Œå¯ä»¥å¯¹RNAè½¬å½•åç”²åŸºåŒ–ä¿®é¥°å›¾è°±è¿›è¡Œå…¨é¢ç ”ç©¶ã€‚ ï¼ˆæœ¬è¯•å‰‚ç›’ä»…ä¾›ç§‘ç ”ç”¨é€”ï¼‰
å®éªŒåŸç†ï¼š



MeRIPåˆ©ç”¨m5Cç‰¹å¼‚æ€§æŠ—ä½“è¯†åˆ«å¹¶ç»“åˆmRNAä¸Šçš„m5Cç”²åŸºåŒ–ä¿®é¥°ä½ç‚¹ï¼Œä»¥RNAå…ç–«å…±æ²‰æ·€æ–¹æ³•å¯Œé›†ç”²åŸºåŒ–ä¿®é¥°ç‰‡æ®µï¼ŒåŒæ—¶ï¼Œç»“åˆé«˜é€šé‡æµ‹åºä¸qPCRï¼Œåœ¨å…¨è½¬å½•ç»„èŒƒå›´å†…ç ”ç©¶å‘ç”Ÿm5Cç”²åŸºåŒ–ä¿®é¥°çš„RNAåŒºåŸŸï¼ŒåŠå…¶å¯¹åŸºå› è¡¨è¾¾çš„è°ƒæ§ä½œç”¨ã€‚

 

äº§å“ä¼˜åŠ¿ï¼š



1. å¿«é€Ÿçœæ—¶

2. ç¨³å®šå¯é 

3.é…å¤‡å®Œæ•´
è´§å·ï¼š
Bes5204-1 m5C MeRIP  
Bes5204-2 m5C MeRIPï¼ˆå«m5CæŠ—ä½“ï¼‰
æ–‡ç« æ¡ˆä¾‹ï¼š



Articleï¼šCHMP4C promotes pancreatic cancer progression by inhibiting necroptosis via the RIPK1/RIPK3/MLKL pathway. 

Periodicalsï¼šJournal of Advanced Research

IFï¼š11.400

Articleï¼šNSUN2 lactylation drives cancer cell resistance to ferroptosis through enhancing GCLC-dependent glutathione synthesis.

Periodicalsï¼šRedox Biology

IFï¼š10.700

Articleï¼šALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion.

Periodicalsï¼šCell death discovery

IFï¼š6.100
m1A MeRIPè¯•å‰‚ç›’
å®éªŒä»‹ç»
MeRIPæœ‰åŠ©äºç ”ç©¶RNAçš„åŒ–å­¦ä¿®é¥°ä»¥åŠå…¶åˆ†å­æœºåˆ¶ï¼ŒRNAç”²åŸºåŒ–ä¼šåœ¨å‡ ä¸ªå±‚é¢å½±å“åŸºå› çš„è¡¨è¾¾:1)å½±å“mRNA çš„ç¨³å®šæ€§:2)å½±å“mRNAçš„å‰ªåˆ‡:3)å½±å“ RNAå’Œè›‹ç™½è´¨çš„ç»“åˆ;4)å½±å“miRNAçš„ç”Ÿæˆç­‰ç­‰ï¼Œå› æ­¤MeRIPåŠ©åŠ›è§£å†³ç»†èƒåˆ†åŒ–ã€ç”Ÿç‰©å‘è‚²ã€ç–¾ç—…å‘ç”Ÿå‘å±•ã€çƒ­ä¼‘å…‹ååº”ç­‰ç”Ÿç‰©å­¦é—®é¢˜
å®éªŒåŸç†ï¼š
    m1A MeRIPåˆ©ç”¨m1Aç‰¹å¼‚æ€§æŠ—ä½“è¯†åˆ«å¹¶ç»“åˆmRNAä¸Šçš„m1Aç”²åŸºåŒ–ä¿®é¥°ä½ç‚¹ï¼Œä»¥RNAå…ç–«å…±æ²‰æ·€æ–¹æ³•å¯Œé›†ç”²åŸºåŒ–ä¿®é¥°ç‰‡æ®µï¼ŒåŒæ—¶ï¼Œç»“åˆé«˜é€šé‡æµ‹åºä¸qPCRï¼Œåœ¨å…¨è½¬å½•ç»„èŒƒå›´å†…ç ”ç©¶å‘ç”Ÿm1Aç”²åŸºåŒ–ä¿®é¥°çš„RNAåŒºåŸŸï¼ŒåŠå…¶å¯¹åŸºå› è¡¨è¾¾çš„è°ƒæ§ä½œç”¨ã€‚MeRIPæœ‰åŠ©äºç ”ç©¶RNAçš„åŒ–å­¦ä¿®é¥°ä»¥åŠå…¶åˆ†å­æœºåˆ¶ï¼ŒRNAç”²åŸºåŒ–ä¼šåœ¨å‡ ä¸ªå±‚é¢å½±å“åŸºå› çš„è¡¨è¾¾:

1)å½±å“mRNAçš„ç¨³å®šæ€§ï¼›

2)å½±å“mRNAçš„å‰ªåˆ‡ï¼›

3)å½±å“ RNAå’Œè›‹ç™½è´¨çš„ç»“åˆï¼›

4)å½±å“miRNAçš„ç”Ÿæˆç­‰ç­‰ï¼Œå› æ­¤MeRIPåŠ©åŠ›è§£å†³ç»†èƒåˆ†åŒ–ã€ç”Ÿç‰©å‘è‚²ã€ç–¾ç—…å‘ç”Ÿå‘å±•ã€çƒ­ä¼‘å…‹ååº”ç­‰ç”Ÿç‰©å­¦é—®é¢˜ã€‚

 

äº§å“ä¼˜åŠ¿ï¼š
1. å¿«é€Ÿçœæ—¶

2. ç¨³å®šå¯é 

3. é…å¤‡å®Œæ•´
è´§å·ï¼š
Bes5206-1 m1A MeRIP  
Bes5206-2 m1A MeRIPï¼ˆå«m1AæŠ—ä½“ï¼‰ 
m7G MeRIPè¯•å‰‚ç›’
å®éªŒä»‹ç»
RNAç”²åŸºåŒ–æŒ‡å‘ç”Ÿåœ¨RNAåˆ†å­ä¸Šä¸åŒä½ç½®çš„ç”²åŸºåŒ–ä¿®é¥°ç°è±¡ï¼Œå±äºè½¬å½•åä¿®é¥°ï¼Œå¸¸è§çš„ç”²åŸºåŒ–ä¿®é¥°æ–¹å¼æœ‰6-ç”²åŸºè…ºå˜Œå‘¤(N6-methyladenosineï¼Œm6A)å’Œ5-ç”²åŸºèƒå˜§å•¶(C5-methylcytidineï¼Œm5C)ä»¥åŠ7-ç”²åŸºé¸Ÿå˜Œå‘¤(N7-methylguanosineï¼Œm7G)ç­‰ã€‚RNAç”²åŸºåŒ–åœ¨è°ƒæ§åŸºå› è¡¨è¾¾ã€å‰ªæ¥ã€RNAç¼–è¾‘ã€RNAç¨³å®šæ€§ã€æ§åˆ¶mRNAå¯¿å‘½å’Œé™è§£ã€ä»‹å¯¼ç¯çŠ¶RNAç¿»è¯‘ç­‰æ–¹é¢å¯èƒ½æ‰®æ¼”é‡è¦è§’è‰²ã€‚åˆ©ç”¨ç”²åŸºåŒ–RNAå…ç–«å…±æ²‰æ·€(Methylated RNA Immunoprecipitationï¼ŒMeRIP)æŠ€æœ¯ï¼Œå¯ä»¥å¯¹RNAè½¬å½•åç”²åŸºåŒ–ä¿®é¥°å›¾è°±è¿›è¡Œå…¨é¢ç ”ç©¶ã€‚ ï¼ˆæœ¬è¯•å‰‚ç›’ä»…ä¾›ç§‘ç ”ç”¨é€”ï¼‰
å®éªŒåŸç†ï¼š



MeRIPåˆ©ç”¨m7Gç‰¹å¼‚æ€§æŠ—ä½“è¯†åˆ«å¹¶ç»“åˆmRNAä¸Šçš„m7Gç”²åŸºåŒ–ä¿®é¥°ä½ç‚¹ï¼Œä»¥RNAå…ç–«å…±æ²‰æ·€æ–¹æ³•å¯Œé›†ç”²åŸºåŒ–ä¿®é¥°ç‰‡æ®µï¼ŒåŒæ—¶ï¼Œç»“åˆé«˜é€šé‡æµ‹åºä¸qPCRï¼Œåœ¨å…¨è½¬å½•ç»„èŒƒå›´å†…ç ”ç©¶å‘ç”Ÿm7Gç”²åŸºåŒ–ä¿®é¥°çš„RNAåŒºåŸŸï¼ŒåŠå…¶å¯¹åŸºå› è¡¨è¾¾çš„è°ƒæ§ä½œç”¨ã€‚

 

äº§å“ä¼˜åŠ¿ï¼š



1. å¿«é€Ÿçœæ—¶

2. ç¨³å®šå¯é 

4.é…å¤‡å®Œæ•´
è´§å·ï¼š
Bes5205-1 m7G MeRIP  
Bes5205-2 m7G MeRIPï¼ˆå«m7GæŠ—ä½“ï¼‰ 
m6A MeRIPè¯•å‰‚ç›’
å®éªŒä»‹ç»
RNAç”²åŸºåŒ–æŒ‡å‘ç”Ÿåœ¨RNAåˆ†å­ä¸Šä¸åŒä½ç½®çš„ç”²åŸºåŒ–ä¿®é¥°ç°è±¡ï¼Œå±äºè½¬å½•åä¿®é¥°ï¼Œå¸¸è§çš„ç”²åŸºåŒ–ä¿®é¥°æ–¹å¼æœ‰6-ç”²åŸºè…ºå˜Œå‘¤(N6-methyladenosineï¼Œm6A)å’Œ5-ç”²åŸºèƒå˜§å•¶(C5-methylcytidineï¼Œm5C)ä»¥åŠ7-ç”²åŸºé¸Ÿå˜Œå‘¤(N7-methylguanosineï¼Œm7G)ç­‰ã€‚RNAç”²åŸºåŒ–åœ¨è°ƒæ§åŸºå› è¡¨è¾¾ã€å‰ªæ¥ã€RNAç¼–è¾‘ã€RNAç¨³å®šæ€§ã€æ§åˆ¶mRNAå¯¿å‘½å’Œé™è§£ã€ä»‹å¯¼ç¯çŠ¶RNAç¿»è¯‘ç­‰æ–¹é¢å¯èƒ½æ‰®æ¼”é‡è¦è§’è‰²ã€‚åˆ©ç”¨ç”²åŸºåŒ–RNAå…ç–«å…±æ²‰æ·€(Methylated RNA Immunoprecipitationï¼ŒMeRIP)æŠ€æœ¯ï¼Œå¯ä»¥å¯¹RNAè½¬å½•åç”²åŸºåŒ–ä¿®é¥°å›¾è°±è¿›è¡Œå…¨é¢ç ”ç©¶ã€‚ ï¼ˆæœ¬è¯•å‰‚ç›’ä»…ä¾›ç§‘ç ”ç”¨é€”ï¼‰
å®éªŒåŸç†ï¼š



MeRIPåˆ©ç”¨m6Aç‰¹å¼‚æ€§æŠ—ä½“è¯†åˆ«å¹¶ç»“åˆmRNAä¸Šçš„m6Aç”²åŸºåŒ–ä¿®é¥°ä½ç‚¹ï¼Œä»¥RNAå…ç–«å…±æ²‰æ·€æ–¹æ³•å¯Œé›†ç”²åŸºåŒ–ä¿®é¥°ç‰‡æ®µï¼ŒåŒæ—¶ï¼Œç»“åˆé«˜é€šé‡æµ‹åºä¸qPCRï¼Œåœ¨å…¨è½¬å½•ç»„èŒƒå›´å†…ç ”ç©¶å‘ç”Ÿm6Aç”²åŸºåŒ–ä¿®é¥°çš„RNAåŒºåŸŸï¼ŒåŠå…¶å¯¹åŸºå› è¡¨è¾¾çš„è°ƒæ§ä½œç”¨ã€‚

 

äº§å“ä¼˜åŠ¿ï¼š



1. å¿«é€Ÿçœæ—¶

2. ç¨³å®šå¯é 

3. é…å¤‡å®Œæ•´

è´§å·ï¼š
Bes5203-1 m6A MeRIP  
Bes5203-2 m6A MeRIPï¼ˆå«m6AæŠ—ä½“ï¼‰ 
æ–‡ç« æ¡ˆä¾‹




ã€2025å¹´ã€‘




Articleï¼šMethylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.

Periodicalsï¼šDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

IFï¼š15.800



Articleï¼šTargeting COPA to Enhance Erdafitinib Sensitivity in FGFR-Altered Bladder Cancer. 

Periodicalsï¼šAdvanced Science (Weinheim, Baden-Wurttemberg, Germany)

IFï¼š14.100




Articleï¼šBetaine inhibits the stem cell-like properties of hepatocellular carcinoma by activating autophagy via SAM/m6A/YTHDF1-mediated enhancement on ATG3 stability. 

Periodicalsï¼šTheranostics

IFï¼š12.400




Articleï¼šThe m6A modification of SOX18 leads to increased PTX3 and cardiomyocyte pyroptosis in sepsis-induced cardiomyopathy. 

Periodicalsï¼šTheranostics

IFï¼š12.400





ChIRPè¯•å‰‚ç›’
å®éªŒä»‹ç»
ChIRPï¼ˆChromatin Isolation by RNA Purificationï¼‰æ˜¯ä¸€é¡¹ç ”ç©¶RNAä¸DNAåŠè›‹ç™½è´¨ä¹‹é—´ç›¸äº’ä½œç”¨çš„æŠ€æœ¯ã€‚æ ¹æ®ç ”ç©¶å¯¹è±¡ä¸åŒï¼ŒChIRPæŠ€æœ¯å¯åˆ†åˆ«ç»“åˆé«˜é€šé‡æµ‹åºï¼ˆChIRP-Seqï¼‰å’Œè´¨è°±æŠ€æœ¯ï¼ˆChIRP-MSï¼‰ï¼Œç ”ç©¶ä¸ç›®æ ‡RNAäº’ä½œçš„åŸºå› å’Œè›‹ç™½è´¨ã€‚ ï¼ˆæœ¬è¯•å‰‚ç›’ä»…ä¾›ç§‘ç ”ç”¨é€”ï¼‰
å®éªŒåŸç†ï¼š



ChIRPæ–¹æ³•é€šè¿‡è®¾è®¡ç”Ÿç‰©ç´ æ ‡è®°RNAäº’è¡¥æ¢é’ˆï¼Œå¹¶ä½¿å…¶ä¸é“¾éœ‰äº²å’Œç´ ç»“åˆï¼Œè¿™æ ·ï¼Œåœ¨æ¢é’ˆä¸ç›®æ ‡RNAç‰¹å¼‚æ€§ç»“åˆçš„åŒæ—¶ï¼Œæ•è·RNAç»“åˆè°ƒæ§çš„DNAæŸ“è‰²ä½“ç‰‡æ®µä¸å‚ä¸è½¬å½•è°ƒæ§çš„RNAç»“åˆè›‹ç™½è´¨ï¼ˆRBPsï¼‰ã€‚



DNAæŸ“è‰²ä½“ç‰‡æ®µç»è¿‡æ–‡åº“æ„å»ºä¸é«˜é€šé‡æµ‹åºï¼Œåœ¨åŸºå› ç»„æ°´å¹³ä¸Šè·å¾—è½¬å½•è°ƒæ§RNAï¼ˆå¢å¼ºå­RNA, eRNAï¼‰è°ƒæ§çš„ä¸‹æ¸¸é¶åŸºå› ï¼Œç»“åˆqPCRå¯ä»¥ç ”ç©¶ç»“åˆè°ƒæ§å¼ºåº¦ï¼› RNAç»“åˆè›‹ç™½ç»è¿‡é…¶æ¶ˆåŒ–ä¸é«˜æ•ˆæ¶²ç›¸-è´¨è°±åˆ†æï¼Œå¯ä»¥é‰´å®šå‚ä¸è½¬å½•è°ƒæ§çš„è›‹ç™½è´¨ï¼Œç»“åˆWestern Blotå¯ä»¥è¿›ä¸€æ­¥ç ”ç©¶ç»“åˆä½œç”¨å¼ºåº¦ã€‚

 

äº§å“ä¼˜åŠ¿ï¼š



1. ä¼¯ä¿¡ç‹¬ç«‹ç ”å‘ï¼Œå…·æœ‰è‡ªä¸»çŸ¥è¯†äº§æƒã€‚

2. ç‰¹å¼‚æ€§å’Œçµæ•åº¦é«˜ï¼Œç¨³å®šæ€§å¥½ã€‚

3. æ£€æµ‹æ–¹æ³•é¢†å…ˆï¼Œç»“æœå‡†ç¡®ã€é‡å¤æ€§å¥½ã€‚

4. å¿«é€Ÿæ£€æµ‹ï¼Œæ“ä½œç®€å•ï¼Œå®‰å…¨ä¾¿æ·ã€‚

è´§å·ï¼š
Bes5104-1 ChIRP-DNA
Bes5104-2 ChIRP-Protein
Bes5104-3 ChIRP-DNAã€Protein
æ³¨ï¼šBes5104-3 ChIRP-DNA&Protein ï¼ˆåŒæ—¶æ‹‰RNAç»“åˆDNAå’Œè›‹ç™½ï¼‰çš„ç”¨æˆ·å¯æ ¹æ®å®éªŒç›®çš„è‡ªè¡Œå‚è€ƒè¯´æ˜ä¹¦Bes5104-1 ChIRP-DNAï¼ˆåªç ”ç©¶RNAç»“åˆDNAï¼‰ æˆ–Bes5104-2 ChIRP-Protein ï¼ˆåªç ”ç©¶RNAç»“åˆè›‹ç™½ï¼‰è¿›è¡Œå®éªŒæ“ä½œã€‚ 
æ–‡ç« æ¡ˆä¾‹
ã€2025å¹´ã€‘

Articleï¼šEnhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer. 


Periodicalsï¼šSignal Transduction and Targeted Therapy

IFï¼š40.800




Articleï¼šo8G-modified circKIAA1797 promotes lung cancer development by inhibiting cuproptosis. 

Periodicalsï¼šJournal of Experimental & Clinincal Cancer Research: CR

IFï¼š11.400




ã€2024å¹´ã€‘






Articleï¼š Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers.


Periodicalsï¼šMilitary Medical Research

IFï¼š16.700




Articleï¼šCircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR-3191-5p. 

Periodicalsï¼šAdvanced Science

IFï¼š14.300



Articleï¼šM6A-mediated upregulation of lncRNA TUG1 in liver cancer cells regulates the antitumor response of CD8+ T cells and phagocytosis of macrophages. 

Periodicalsï¼šAdvanced Science

IFï¼š14.300




ChIPè¯•å‰‚ç›’
å®éªŒä»‹ç»
æŸ“è‰²è´¨å…ç–«æ²‰æ·€ï¼ˆChIPï¼‰æ˜¯ç ”ç©¶ä½“å†…è›‹ç™½è´¨ä¸DNAç›¸äº’ä½œç”¨çš„ç†æƒ³æŠ€æœ¯ï¼Œæ˜¯ç›®å‰ç ”ç©¶è½¬å½•å› å­ï¼ˆtranscription, TFï¼‰ä¸å¯åŠ¨å­ï¼ˆpromoterï¼‰åŒºåŸŸé—´ç›¸äº’è”ç³»çš„è¾ƒå¥½æ–¹æ³•ã€‚ChIPä¸å…¶ä»–å®éªŒæŠ€æœ¯ç›¸ç»“åˆï¼Œå¯ç”¨äºä¸åŒç”¨é€”çš„æ£€æµ‹ã€‚ChIP-Seqæ–¹æ³•ç‰¹å¼‚æ€§åœ°å¯Œé›†ä¸ç›®çš„è›‹ç™½ç»“åˆçš„DNAç‰‡æ®µï¼Œå¹¶å¯¹å¯Œé›†å¾—åˆ°çš„DNAç‰‡æ®µè¿›è¡Œé«˜é€šé‡æµ‹åºï¼Œä»è€Œç¡®å®šè¯¥è½¬å½•å› å­ä¸åŸºå› ç»„çš„ç»“åˆåŒºåŸŸã€‚ ï¼ˆæœ¬è¯•å‰‚ç›’ä»…ä¾›ç§‘ç ”ç”¨é€”ï¼‰
å®éªŒåŸç†ï¼š



åœ¨æ´»ç»†èƒçŠ¶æ€ä¸‹ä½¿ç»†èƒå†…çš„è›‹ç™½è´¨å’ŒDNAäº¤è”ï¼Œå¹¶ç”¨è¶…å£°æ³¢å°†å…¶éšæœºåˆ‡æ–­ä¸ºä¸€å®šé•¿åº¦èŒƒå›´å†…çš„æŸ“è‰²è´¨å°ç‰‡æ®µã€‚é€‰æ‹©ä¸ç›®çš„è›‹ç™½ç‰¹å¼‚æ€§ç»“åˆçš„æŠ—ä½“å…ç–«æ²‰æ·€DNA-è›‹ç™½è´¨å¤åˆä½“ï¼Œä»è€Œç‰¹å¼‚æ€§åœ°å¯Œé›†ä¸ç›®çš„è›‹ç™½ç»“åˆçš„æŸ“è‰²ä½“ç‰‡æ®µã€‚

 



äº§å“ä¼˜åŠ¿ï¼š



1. é«˜æ•ˆåŠç‰¹å¼‚çš„å¯Œé›†æ•ˆç‡ï¼›é˜³æ€§å’Œé˜´æ€§å¯¹ç…§çš„å¯Œé›†æ¯”ç‡>120ã€‚

2. å¯¹ä¸‹æ¸¸åˆ†ææ–¹æ³•çš„å…¼å®¹æ€§å¼ºï¼Œå¯å…¼å®¹RT-qPCRã€åŸºå› èŠ¯ç‰‡å’Œé«˜é€šé‡æµ‹åºç­‰ã€‚

3.ä¼˜ç§€çš„æŠ€æœ¯æœåŠ¡å›¢é˜Ÿï¼ŒæŠ€æœ¯æœåŠ¡é«˜æ•ˆã€å…¨é¢ã€è¿…é€Ÿï¼Œèƒ½åŠæ—¶å¸®åŠ©å®¢æˆ·å°½å¿«è§£å†³å®éªŒä¸­é‡åˆ°çš„é—®é¢˜ã€‚
è´§å·ï¼š
Bes5001 ChIPï¼ˆåŠ¨ç‰©ï¼‰
Bes5002 ChIPï¼ˆæ¤ç‰©ï¼‰
æ–‡ç« æ¡ˆä¾‹



ã€2025å¹´ã€‘



Articleï¼š Long-chain acylcarnitine deficiency promotes hepatocarcinogenesis.

Periodicalsï¼šActa pharmaceutica Sinica. B

IFï¼š14.700




Articleï¼š A glucose-enriched lung pre-metastatic niche triggered by matrix stiffness-tuned exosomal miRNAs in hepatocellular carcinoma.

Periodicalsï¼šNature Communications

IFï¼š14.700



Articleï¼š Eriodictyol-cisplatin coated nanomedicine synergistically promote osteosarcoma cells ferroptosis and chemosensitivity.

Periodicalsï¼šJournal of Nanobiotechnology

IFï¼š12.600



Articleï¼šTargeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma. 

Periodicalsï¼šScience Advances

IFï¼š12.500





DNA pulldownè¯•å‰‚ç›’
å®éªŒä»‹ç»
DNA pulldownæ˜¯ä¸€ç§ç”¨äºç ”ç©¶DNAä¸è›‹ç™½è´¨äº’ä½œçš„æŠ€æœ¯ã€‚é€šå¸¸ç”¨æ¥åˆ†æç›®æ ‡åŸºå› è°ƒæ§åŒºåŸŸç›¸ç»“åˆçš„è½¬å½•å› å­åŠå…¶ä»–è°ƒæ§è›‹ç™½ã€‚ ï¼ˆæœ¬è¯•å‰‚ç›’ä»…ä¾›ç§‘ç ”ç”¨é€”ï¼‰
è¯¦ç»†ä»‹ç»


å®éªŒåŸç†ï¼š



é’ˆå¯¹ç›®æ ‡åŒºåŸŸè®¾è®¡ç”Ÿç‰©ç´ æ ‡è®°çš„ç‰¹å¼‚æ€§DNAæ¢é’ˆå¶è”ç£ç ï¼Œå¹¶ä¸ç»†èƒæ ¸æå–ç‰©å­µè‚²ã€‚è›‹ç™½åˆ†å­ä¸DNAæ¢é’ˆç‰¹å¼‚æ€§ç»“åˆï¼Œé€šè¿‡æ´—è„±ï¼Œå¾—åˆ°ç›®çš„DNAæ¢é’ˆ-è›‹ç™½è´¨å¤åˆç‰©ã€‚æœ€åé‡‡ç”¨Western Blotæˆ–è´¨è°±é‰´å®šè›‹ç™½è´¨ç±»å‹ã€‚

 

äº§å“ä¼˜åŠ¿ï¼š



1.è‡ªä¸»å“ç‰Œï¼šæ‹¥æœ‰è‡ªä¸»çŸ¥è¯†äº§æƒä¸“åˆ©ã€‚

2.å¿«é€Ÿçœæ—¶ï¼šä»æ ‡è®°æ¢é’ˆåˆ°ç»“æœåˆ†æï¼Œæ‰€è´¹æ—¶é—´æ˜¾è‘—å‡å°‘ã€‚

3.ç¨³å®šå¯é ï¼šDNAæœ«ç«¯æ ‡è®°ç”Ÿç‰©ç´ ï¼Œä¸å½±å“è›‹ç™½ç»“åˆä½ç‚¹ã€‚æ ‡è®°å¥½çš„DNAå¯ä»¥ä¿å­˜ä¸€å¹´ã€‚

4.é…å¤‡å®Œæ•´ï¼šåªéœ€è¦è‡ªå¤‡ç”Ÿç‰©ç´ æœ«ç«¯æ ‡è®°çš„DNAæ¢é’ˆåŠæ ¸è›‹ç™½è´¨æ ·å“ã€‚

5.å¯å¾—åˆ°å®Œæ•´ã€é«˜æµ“åº¦è›‹ç™½ï¼Œç”¨äºè´¨è°±æ£€æµ‹ã€‚

è´§å·ï¼šBes5004 DNA pulldown
æ–‡ç« æ¡ˆä¾‹







Articleï¼šShort-term starvation inhibits CD36 N-glycosylation and downregulates USP7 UFMylation to alleviate RBPJ-maintained T cell exhaustion in liver cancer.

Periodicalsï¼šTheranostics

IFï¼š13.300



Articleï¼šKRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC.

Periodicalsï¼šCell reports. Medicine

IFï¼š11.700





Articleï¼šStructural variants involved in high-altitude adaptation detected using single-molecule long-read sequencing.

Periodicalsï¼šNature conmunications

IFï¼š14.700





miRNA pulldown è¯•å‰‚ç›’
å®éªŒåŸç†ï¼š

å°†ç”Ÿç‰©ç´ æ ‡è®°çš„miRNAæ¢é’ˆè½¬æŸ“åˆ°ç»†èƒä¸­ï¼Œä½¿ç»†èƒè£‚è§£ç‰©ä¸­çš„ç”Ÿç‰©ç´ æ ‡è®°miRNA-RNAå¤åˆç‰©èƒ½å¤Ÿè¢«é“¾éœ‰äº²å’Œç´ ç£ç é«˜æ•ˆå¯Œé›†ï¼Œä»è€Œä¸è£‚è§£æ¶²ä¸­å…¶ä»–æˆåˆ†åˆ†ç¦»ï¼›éšåï¼Œé€šè¿‡æ´—è„±çº¯åŒ–å¾—åˆ°RNAå¹¶è¿›è¡Œé«˜é€šé‡æµ‹åºæˆ–qPCRæ£€æµ‹ï¼ŒéªŒè¯miRNAçš„é¶åŸºå› ã€‚æ­¤å¤–ï¼Œè¿˜å¯ä»¥é€šè¿‡æ´—è„±çº¯åŒ–è·å¾—ç»“åˆåœ¨RNAä¸Šçš„è›‹ç™½å¹¶è¿›è¡Œè´¨è°±æ£€æµ‹æˆ–Western blotæ£€æµ‹ã€‚



äº§å“ä¼˜åŠ¿ï¼š



1. é«˜å“è´¨ï¼Œç¨³å®šæ€§å¥½ã€‚

2. æ˜“ç”¨ï¼šæ“ä½œç®€å•ï¼Œå®¹æ˜“ä¸Šæ‰‹ã€‚

4.ç²¾å‡†ï¼šç‰¹å¼‚æ€§é«˜ï¼ŒèƒŒæ™¯å°‘ã€‚
è´§å·ï¼š
Bes5108 miRNA pulldown-RNA
Bes5109 miRNA pulldown-Protein





æ–‡ç« æ¡ˆä¾‹






Articleï¼š Targeting piRNA-137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via De Novo Cholesterol Biosynthesis in Lung Adenocarcinoma. 

Periodicalsï¼šAdvanced science (Weinheim, Baden-Wurttemburg, Germany)

IFï¼š14.100



Articleï¼šA tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity.

Periodicalsï¼šJournal of experimental & clinical cancer research

IFï¼š11.400








Articleï¼šLong noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-ÎºB pathway

Periodicalsï¼šJournal of Experimental & Clinical Cancer Research

IFï¼š11.16




RAPè¯•å‰‚ç›’
å®éªŒä»‹ç»
RNA åä¹‰çº¯åŒ–æŠ€æœ¯ï¼ˆRNA Antisense Purificationï¼ŒRAPï¼‰ç”¨äºç ”ç©¶RNAä¸RNAã€RNAä¸è›‹ç™½è´¨ä¹‹é—´çš„ç›¸äº’ä½œç”¨ã€‚æ ¹æ®ç ”ç©¶å¯¹è±¡ä¸åŒï¼ŒRAPæŠ€æœ¯ç»“åˆäº†é«˜é€šé‡æµ‹åºï¼ˆRAP-Seqï¼‰å’Œè´¨è°±æŠ€æœ¯ï¼ˆRAP-MSï¼‰ï¼Œåˆ†åˆ«ç ”ç©¶ä¸ç›®æ ‡RNAäº’ä½œçš„RNAå’Œè›‹ç™½è´¨ã€‚ ï¼ˆæœ¬è¯•å‰‚ç›’ä»…ä¾›ç§‘ç ”ç”¨é€”ï¼‰
å®éªŒåŸç†ï¼š


RAPæŠ€æœ¯é€šè¿‡è®¾è®¡ç”Ÿç‰©ç´ æ¢é’ˆç»„æ‹‰å–ç›®æ ‡RNAï¼Œä½¿ä¸å…¶å…±åŒä½œç”¨çš„RNAæˆ–è›‹ç™½è´¨ï¼ˆRBPsï¼‰å¯Œé›†åœ¨ç£ç ä¸Šå¹¶è¢«æ´—è„±ã€‚æœ€åï¼Œé€šè¿‡é«˜é€šé‡æµ‹åºå¾—åˆ°è¯¥è°ƒæ§RNAè½¬å½•è°ƒæ§çš„ä¸‹æ¸¸é¶åŸºå› ï¼ŒåŒæ—¶ï¼Œä¹Ÿå¯ä»¥é€šè¿‡Western BlotéªŒè¯RBPsï¼Œæˆ–é€šè¿‡MSé‰´å®šæœªçŸ¥è›‹ç™½ã€‚

 

äº§å“ä¼˜åŠ¿ï¼š



1. ä¼¯ä¿¡ç‹¬ç«‹ç ”å‘ï¼Œå…·æœ‰è‡ªä¸»çŸ¥è¯†äº§æƒã€‚

2. çµæ•åº¦é«˜ï¼Œç¨³å®šæ€§å¥½ã€‚

3. æ£€æµ‹æ–¹æ³•é¢†å…ˆï¼Œç»“æœå‡†ç¡®ã€é‡å¤æ€§å¥½ã€‚
è´§å·ï¼š
Bes5103-1 RAP-RNA
Bes5103-2 RAP-Protein
Bes5103-3 RAP-RNA Protein

æ³¨ï¼šBes5103-3 RAP-RNA&Protein ï¼ˆåŒæ—¶æ‹‰RNAç»“åˆRNAå’Œè›‹ç™½ï¼‰çš„ç”¨æˆ·å¯æ ¹æ®å®éªŒç›®çš„è‡ªè¡Œå‚è€ƒè¯´æ˜ä¹¦Bes5103-1 RAP-RNAï¼ˆåªç ”ç©¶RNAç»“åˆRNAï¼‰ æˆ–Bes5103-2 RAP-Protein ï¼ˆåªç ”ç©¶RNAç»“åˆè›‹ç™½ï¼‰è¿›è¡Œå®éªŒæ“ä½œã€‚


æ–‡ç« æ¡ˆä¾‹


ã€2025å¹´ã€‘





Articleï¼šTargeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. 

Periodicalsï¼šDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

IFï¼š15.800




Articleï¼šIdentification of a JAKâ€“STATâ€“miR155HG positive feedback loop in regulating natural killer (NK) cells proliferation and effector functions

Periodicalsï¼šActa Pharmaceutica Sinica B

IFï¼š14.700





Articleï¼š Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer.

Periodicalsï¼šMolecular cancer

IFï¼š27.700




Articleï¼šExosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway.

Periodicalsï¼šMolecular cancer

IFï¼š27.700




Articleï¼šEscherichia coli-Induced cGLIS3-Mediated Stress Granules Activate the NF-ÎºB Pathway to Promote Intrahepatic Cholangiocarcinoma Progression. 

Periodicalsï¼šAdvanced Science

IFï¼š14.300



Reverse-ChIPè¯•å‰‚ç›’
å®éªŒä»‹ç»
åå‘æŸ“è‰²è´¨å…ç–«å…±æ²‰æ·€æŠ€æœ¯ï¼ˆreverse chromatin immunoprecipitation assayï¼ŒReverse ChIPï¼‰ç›¸å¯¹åº”äºæŸ“è‰²è´¨å…ç–«å…±æ²‰æ·€æŠ€æœ¯ï¼ˆChIPï¼‰ï¼Œæ˜¯ä¸€ç§åœ¨ä½“å†…çŠ¶æ€ä¸‹åˆ†æ DNA-è›‹ç™½è´¨ç›¸äº’ä½œç”¨çš„æ–°æ–¹æ³•ã€‚è¯¥æ–¹æ³•å¯å¯¹é¶ DNA ä½ç‚¹ç›¸å…³è›‹ç™½è´¨è¿›è¡Œå…¨é¢ã€ç³»ç»Ÿçš„é‰´å®šï¼Œç‰¹åˆ«æ˜¯å¯»æ‰¾å·²çŸ¥DNA å…ƒä»¶ç›¸åº”çš„è°ƒæ§è›‹ç™½ã€‚åœ¨å‘ç°ã€é‰´å®šæœªçŸ¥è°ƒæ§è›‹ç™½å’Œç ”ç©¶ DNA-è›‹ç™½è´¨ç›¸äº’ä½œç”¨ä¸­æœ‰é‡è¦åº”ç”¨ä»·å€¼ã€‚é™¤ç»†èƒå¤–ï¼ŒReverse ChIPä¹Ÿå¯åº”ç”¨äºå¾®ç”Ÿç‰©ã€æ¤ç‰©ç­‰æ ·æœ¬ã€‚ ï¼ˆæœ¬è¯•å‰‚ç›’ä»…ä¾›ç§‘ç ”ç”¨é€”ï¼‰
å®éªŒåŸç†ï¼š



å°†ç»†èƒå†…çš„è›‹ç™½è´¨å’ŒDNAäº¤è”åï¼Œåˆ©ç”¨è¶…å£°æ³¢å°†å·²äº¤è”çš„DNAéšæœºåˆ‡æ–­ä¸ºä¸€å®šé•¿åº¦èŒƒå›´å†…çš„æŸ“è‰²è´¨å°ç‰‡æ®µï¼Œç„¶åç”¨ç‰¹å¼‚çš„æ ¸é…¸æ¢é’ˆæ•è·é¶DNAç‰‡æ®µå’Œä¸å…¶ç»“åˆçš„è›‹ç™½è´¨ï¼Œæœ€åï¼Œç”¨Western Blotæˆ–è´¨è°±æ£€æµ‹å’Œé‰´å®šç»“åˆäºé¶DNAä½ç‚¹çš„å…¨éƒ¨ç›¸å…³è›‹ç™½è´¨ã€‚

 



æŠ€æœ¯åº”ç”¨ï¼š



1.ç ”ç©¶ä½“å†…ä¸ç‰¹å®šDNA åºåˆ—ç»“åˆçš„è°ƒæ§è›‹ç™½ã€‚

2.Reverse-ChIPæŠ€æœ¯ç»“åˆ LC-MS å¯é«˜é€šé‡ç­›é€‰æœªçŸ¥ç»“åˆè°ƒæ§è›‹ç™½ç±»å‹ã€‚

 

äº§å“ä¼˜åŠ¿ï¼š



1.ä¼¯ä¿¡ç‹¬ç«‹ç ”å‘ã€‚

2.å¿«é€Ÿçœæ—¶ã€‚

3.å¯é‡å¤æ€§å¥½ï¼Œç‰¹å¼‚æ€§å¼ºï¼Œçµæ•åº¦é«˜ã€‚

4.æ“ä½œç®€ä¾¿ã€ç»“æœå‡†ç¡®å¯é ã€‚

è´§å·ï¼šBes5005 reverse-ChIP
æ–‡ç« æ¡ˆä¾‹



Articleï¼šHypoxia promotes EV secretion by impairing lysosomal homeostasis in HNSCC through negative regulation of ATP6V1Aby HIF-1Î±

Periodicalsï¼šJournal of Extracellular Vesicles

IFï¼š16.000



Articleï¼šDysfunction of astrocytic glycophagy exacerbates reperfusion injury in ischemic stroke.

Periodicalsï¼šRedox biology

IFï¼š10.700


RIPè¯•å‰‚ç›’
å®éªŒä»‹ç»
RNA Immunoprecipitationï¼ˆRIPï¼‰æ˜¯ç ”ç©¶ç»†èƒå†…RNAä¸è›‹ç™½è´¨ç»“åˆçš„æŠ€æœ¯ï¼Œæ˜¯äº†è§£è½¬å½•åè°ƒæ§ç½‘ç»œåŠ¨æ€è¿‡ç¨‹çš„æœ‰åŠ›å·¥å…·ï¼Œå¯åº”ç”¨äºmiRNAè°ƒæ§é¶ç‚¹ã€RNA ä¸ RBPsï¼ˆRNAç»“åˆè›‹ç™½ï¼‰äº’ä½œç­‰ç ”ç©¶ã€‚ ï¼ˆæœ¬è¯•å‰‚ç›’ä»…ä¾›ç§‘ç ”ç”¨é€”ï¼‰
å®éªŒåŸç†ï¼š



RIPæŠ€æœ¯è¿ç”¨é’ˆå¯¹ç›®æ ‡è›‹ç™½çš„æŠ—ä½“å…ç–«æ²‰æ·€ç›¸åº”çš„RNA-è›‹ç™½å¤åˆç‰©ï¼Œå¹¶çº¯åŒ–ä¸è›‹ç™½ç»“åˆçš„RNAã€‚æœ€åï¼Œç»“åˆåŸºå› ç‰¹å¼‚æ€§åˆ†ææŠ€æœ¯ï¼ˆPCRã€qRT-PCRï¼‰æˆ–é«˜é€šé‡åˆ†ææŠ€æœ¯ï¼ˆé«˜é€šé‡æµ‹åºã€åŸºå› èŠ¯ç‰‡ï¼‰ï¼Œåˆ†æç»“åˆåœ¨å¤åˆç‰©ä¸Šçš„RNAç±»å‹åŠæ•°é‡ã€‚

 

äº§å“ä¼˜åŠ¿ï¼š



1. ä¼¯ä¿¡ç‹¬ç«‹ç ”å‘ã€‚

2. æä¾›ä¼˜åŒ–çš„ç£ç ï¼Œé€‚äºå…ç–«æ²‰æ·€RNA-è›‹ç™½å¤åˆç‰©ã€‚

3. é«˜å“è´¨ï¼Œç¨³å®šæ€§å¥½ï¼Œ

4. ç»“æœå‡†ç¡®ï¼Œé‡å¤æ€§å¥½ã€‚

5. æ“ä½œç®€å•ï¼Œå¿«é€Ÿçœæ—¶ã€‚

è´§å·ï¼šBes5101 RIP(12Tã€24Tã€40T)
æ–‡ç« æ¡ˆä¾‹

ã€2025å¹´ã€‘


Articleï¼šThe cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis.

Periodicalsï¼šSignal Transduction and Targeted Therapy

IFï¼š40.800




Articleï¼šCircAKT3 promotes prostate cancer proliferation and metastasis by enhancing the binding of RPS27A and RPL11.

Periodicalsï¼šMolecular Cancer

IFï¼š27.700




Articleï¼šEIF4E-mediated biogenesis of circPHF14 promotes the growth and metastasis of pancreatic ductal adenocarcinoma via Wnt/Î²-catenin pathway.

Periodicalsï¼šMolecular Cancer

IFï¼š27.700



Articleï¼šMethylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.

Periodicalsï¼šDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

IFï¼š15.800




RNA pulldownè¯•å‰‚ç›’
å®éªŒä»‹ç»
è›‹ç™½è´¨ä¸RNAçš„ç›¸äº’ä½œç”¨æ˜¯è®¸å¤šç»†èƒç”Ÿç‰©å­¦è¿‡ç¨‹çš„æ ¸å¿ƒï¼Œå¦‚è›‹ç™½è´¨åˆæˆã€mRNA ç»„è£…ã€ç—…æ¯’å¤åˆ¶ã€ç»†èƒå‘è‚²è°ƒæ§ç­‰ï¼Œç ”ç©¶å®ƒä»¬ä¹‹é—´ç›¸äº’ä½œç”¨çš„åˆ†å­æœºåˆ¶å¯¹ç†è§£è¿™äº›ç”Ÿç‰©å­¦è¿‡ç¨‹éå¸¸é‡è¦ã€‚RNA pulldownæŠ€æœ¯é€šè¿‡ä½“å¤–è½¬å½•æ ‡è®°ç”Ÿç‰©ç´ çš„RNAæ¢é’ˆè€¦è”é“¾éœ‰äº²å’Œç´ æ ‡è®°çš„ç£ç ï¼Œå®ç°äº†å¯¹RNAç»“åˆè›‹ç™½è´¨ï¼ˆRBPsï¼‰çš„é«˜æ•ˆå¯Œé›†å’Œé‰´å®šã€‚ ï¼ˆæœ¬è¯•å‰‚ç›’ä»…ä¾›ç§‘ç ”ç”¨é€”ï¼‰
å®éªŒåŸç†ï¼š



é’ˆå¯¹ç›®æ ‡åŒºåŸŸè®¾è®¡ç”Ÿç‰©ç´ æ ‡è®°çš„ç‰¹å¼‚æ€§RNAæ¢é’ˆå¶è”ç£ç ï¼Œå¹¶ä¸ç»†èƒè›‹ç™½æå–ç‰©å­µè‚²ï¼Œè›‹ç™½åˆ†å­ä¸RNAæ¢é’ˆç‰¹å¼‚æ€§ç»“åˆï¼Œç»æ´—è„±ï¼Œå¾—åˆ°ç›®çš„RNAæ¢é’ˆ-è›‹ç™½è´¨å¤åˆç‰©ã€‚æœ€åé‡‡ç”¨Western Blotæˆ–è´¨è°±é‰´å®šè›‹ç™½è´¨ç±»å‹ã€‚

 

äº§å“ä¼˜åŠ¿ï¼š



1. è‡ªä¸»å“ç‰Œï¼šæ‹¥æœ‰è‡ªä¸»çŸ¥è¯†äº§æƒä¸“åˆ©ã€‚

2. é«˜å“è´¨ï¼Œç¨³å®šæ€§å¥½ã€‚

3. ç²¾å‡†ï¼šç‰¹å¼‚æ€§é«˜ï¼ŒèƒŒæ™¯å°‘ã€‚

4. æ˜“ç”¨ï¼šæ“ä½œç®€å•ï¼Œå®¹æ˜“ä¸Šæ‰‹ã€‚

5.å¿«é€Ÿçœæ—¶ã€‚
è´§å·ï¼šBes5102 RNA pulldownï¼ˆ12Tã€24Tã€40Tï¼‰
æ–‡ç« æ¡ˆä¾‹

ã€2025å¹´ã€‘



Articleï¼šCircAKT3 promotes prostate cancer proliferation and metastasis by enhancing the binding of RPS27A and RPL11.

Periodicalsï¼šMolecular Cancer

IFï¼š27.700



Articleï¼š Sperm-Derived CircRNA-1572 Regulates Embryogenesis and Zygotic Genome Activation by Targeting CCNB2 via Bta-miR-2478-L-2. 

Periodicalsï¼šAdvanced science (Weinheim, Baden-Wurttemberg, Germany)

IFï¼š14.100



Articleï¼š LncRNA TUG1 Repressed Angiogenesis by Promoting the Ubiquitination of HuR and Inhibiting Its Nuclear Translocation in Cerebral Ischemic Reperfusion Injury. 

Periodicalsï¼šAdvanced science (Weinheim, Baden-Wurttemberg, Germany)

IFï¼š14.100




TRAPè¯•å‰‚ç›’
å®éªŒä»‹ç»
TRAP( tagged RNA affinity purification)æ˜¯ä¸€ç§é€šè¿‡è®¾è®¡ncRNA-MS2è½½ä½“ä¸GST-MS2èåˆè¡¨è¾¾è½½ä½“å¹¶å…±è½¬ç»†èƒï¼Œä»¥æ£€æµ‹ä¸ncRNAç»“åˆçš„è›‹ç™½è´¨ï¼ˆRBPsï¼‰æˆ–RNAçš„ç ”ç©¶æ–¹æ³•ã€‚æ ¹æ®ç ”ç©¶å¯¹è±¡çš„ä¸åŒï¼ŒTRAPå¯ä¸é«˜é€šé‡æµ‹åºã€qPCRè”ç”¨ï¼Œé‰´å®šä¸ncRNAç»“åˆçš„RNAç§ç±»ä¸ç›¸äº’ä½œç”¨æ°´å¹³ï¼›æˆ–æ˜¯ä¸MSã€Western blotè”ç”¨ï¼Œé‰´å®šä¸ncRNAç»“åˆçš„è›‹ç™½è´¨ç§ç±»ä¸ç»“åˆå¼ºåº¦ã€‚ ï¼ˆæœ¬è¯•å‰‚ç›’ä»…ä¾›ç§‘ç ”ç”¨é€”ï¼‰
å®éªŒåŸç†ï¼š



TRAPæ–¹æ³•é¦–å…ˆè®¾è®¡GST-MS2èåˆè¡¨è¾¾è½½ä½“å’ŒncRNA-MS2èŒç¯ç»“æ„ä¸²è”é‡å¤è½½ä½“ï¼Œå…±è½¬ç»†èƒè·å¾—GST-MS2èåˆè›‹ç™½å’ŒncRNA-MS2èåˆRNAï¼Œåœ¨èƒå†…å½¢æˆGST-MS2~ncRNA-MS2ä¸è›‹ç™½æˆ–RNAçš„å¤åˆä½“ï¼›ç„¶åè£‚è§£ç»†èƒï¼Œåˆ©ç”¨è°·èƒ±ç”˜è‚½äº²å’Œç¼è„‚ç³–ç£ç æ‹‰å–è·å¾—ç›®çš„è›‹ç™½-RNAå¤åˆç‰©ï¼›æœ€åè¿›ä¸€æ­¥åˆ†ç¦»çº¯åŒ–ï¼Œè·å¾—ç›®çš„è›‹ç™½æˆ–ç›®çš„RNAè¿›è¡Œä¸‹ä¸€æ­¥æ£€æµ‹åˆ†æã€‚

äº§å“ä¼˜åŠ¿ï¼š

1. ä¼¯ä¿¡ç‹¬ç«‹ç ”å‘ã€‚

2. è§£å†³äº†ä¼ ç»Ÿçš„TRAPå®éªŒç›®å‰åªåº”ç”¨äºLncRNAç­‰äº’ä½œRNAæˆ–è›‹ç™½ç ”ç©¶çš„å±€é™æ€§é—®é¢˜ã€‚

3.ä½¿ç”¨ç¯çŠ¶RNAè¡¨è¾¾è½½ä½“è€Œéæ¢é’ˆè¿›è¡Œæ‚äº¤ï¼Œé¿å…äº†circRNAç ”ç©¶ä¸­æ¥å¤´åºåˆ—è¢«è›‹ç™½ç»“åˆåæ¢é’ˆä¸èƒ½ç»“åˆcircRNAå¯¼è‡´çš„å‡é˜´æ€§å½±å“ï¼Œä¸”é™ä½äº†æ¢é’ˆæ‚äº¤è¿‡ç¨‹ä¸­RNAçš„é™è§£ã€‚
è´§å·ï¼šBes5106 TRAP 
æ–‡ç« æ¡ˆä¾‹


Articleï¼š o8G-modified circPLCE1 inhibits lung cancer progression via chaperone-mediated autophagy. 

Periodicalsï¼šMolecular Cancer

IFï¼š27.700




Articleï¼šo8G-modified circKIAA1797 promotes lung cancer development by inhibiting cuproptosis. 

Periodicalsï¼šJournal of Experimental & Clinincal Cancer Research: CR

IFï¼š11.400





Articleï¼šCirc6834 suppresses non-small cell lung cancer progression by destabilizing ANHAK and regulating miR-873-5p/TXNIP axis.

Periodicalsï¼šMolecular Cancer

IFï¼š27.700




Articleï¼šcircEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-Î² signalling pathway-mediated activation of MMPs in pancreatic cancer

Periodicalsï¼šMolecular Cancer

IFï¼š37.299



Articleï¼šLINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling

Periodicalsï¼šMolecular Cancer

IFï¼š37.299




Articleï¼šCircular RNA EIF4G3 suppresses gastric cancer progression through inhibition of Î²-catenin by promoting Î´-catenin ubiquitin degradation and upregulating SIK1

Periodicalsï¼šMolecular Cancer

IFï¼š37.299


3Cè¯•å‰‚ç›’
å®éªŒä»‹ç»
æŸ“è‰²ä½“æ„è±¡æ•è·æŠ€æœ¯ï¼ˆchromosome conformation captureï¼Œ3Cï¼‰ï¼Œæ˜¯é©æ–°æ€§çš„ç»˜åˆ¶æŸ“è‰²è´¨ç›¸äº’ä½œç”¨çš„å·¥å…·ï¼Œåº”ç”¨äºé…µæ¯ä¸­ç ”ç©¶åŸºå› è¡¨è¾¾æ—¶ï¼ŒæŸ“è‰²è´¨çš„ç©ºé—´æ„è±¡åˆ†æï¼Œç»§è€Œå‘å±•ä¸ºåœ¨åç”ŸåŠ¨ç‰©ä¸­ç ”ç©¶ç»†èƒå†…æŸ“è‰²è´¨é—´çš„ç›¸äº’ä½œç”¨ï¼›3C æŠ€æœ¯ï¼Œèƒ½ä»å…¨åŸºå› ç»„çš„è§’åº¦è¯ é‡Šäº†è›‹ç™½è´¨å› å­ä¸æŸ“è‰²è´¨ç›¸äº’ä½œç”¨çš„å…³ç³»ï¼Œä»¥åŠç»†èƒæ ¸å†…äº’ä½œæŸ“è‰²è´¨çš„ç©ºé—´æ„è±¡ã€‚
è¯¦ç»†ä»‹ç»
åŸºæœ¬åŸç†ï¼š
åˆ©ç”¨ç”²é†›å›ºå®šç»†èƒå†…çš„æŸ“è‰²è´¨ï¼Œç„¶åé€šè¿‡é™åˆ¶æ€§å†…åˆ‡é…¶æ‰“æ–­DNAï¼Œé‡‡ç”¨è¿æ¥é…¶ä½¿å¾—è¢«äº¤è”åœ¨ä¸€èµ·çš„DNAç‰‡æ®µä¹‹é—´èƒ½å¤Ÿå‘ç”Ÿé‚»ä½è¿æ¥ï¼Œç„¶åé€šè¿‡åœ¨ä¸¤ä¸ªåŸºå› çš„é…¶åˆ‡ä½ç‚¹é™„è¿‘è®¾è®¡å¼•ç‰©ï¼Œè‹¥ä¸¤è€…æœ‰ç›¸äº’ä½œç”¨ï¼Œåˆ™åœ¨é…¶åˆ‡å’Œè¿æ¥å¤„ç†ä¹‹åï¼Œä¸¤è€…çš„çº¿æ€§ä½ç½®ä¼šè·ç¦»å¾ˆè¿‘ï¼Œå¯ä»¥é€šè¿‡PCRååº”æ‰©å¢å‡ºæ¥ï¼Œè‹¥ä¸¤è€…æ— ç›¸äº’ä½œç”¨ï¼Œåˆ™ç»è¿‡å¤„ç†åçº¿æ€§ä½ç½®ä»ç„¶ç›¸è·å¾ˆè¿œï¼Œä¸èƒ½è¢«æ‰©å¢å‡ºæ¥ã€‚
äº§å“ç‰¹ç‚¹ï¼š



1.æ“ä½œç®€ä¾¿ï¼Œç»“æœå‡†ç¡®å¯é 

2.é…å¤‡å®Œæ•´

3.ä¼¯ä¿¡ç‹¬ç«‹ç ”å‘

è´§å·ï¼šBes5006 3C 12T

Bes5006 3C 40T
æ–‡ç« æ¡ˆä¾‹
ã€2024å¹´ã€‘

Articleï¼š CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma. 

Periodicalsï¼šCancer Letters

IFï¼š9.100</p>
        <p>2023.10.01 ä»Šå¤©å­¦ä¼šäº†åˆ›å»ºè‡ªå·±çš„ç½‘é¡µï¼</p>
    </div>
</body>
</html>